Procyon Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
Procyon Advisors's MEDP Position: Q3 2026 in Review
Procyon Advisors increased its Medpace (MEDP) stake by 0.85% in Q3 2026, buying an estimated $3.52K and bringing the position to 711 shares worth $444K. The position accounts for 0.02% of the portfolio, ranked #381.
Procyon Advisors first reported a position in MEDP in Q1 2022 and has held it in 18 quarters since. The position peaked at $732K in Q4 2023. 143 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.
- Procyon Advisors held 711 shares of Medpace worth $444K as of Q3 2026.
- Procyon Advisors bought 6 Medpace shares in Q3 2026, an estimated $3.52K.
- Medpace made up 0.02% of Procyon Advisors's portfolio in Q3 2026, its #381 holding.
- Procyon Advisors first reported a position in Medpace in Q1 2022 and has held it in 18 quarters since.
- Procyon Advisors's Medpace position peaked at $732K in Q4 2023.
- 143 funds tracked by Wall St. Rank held Medpace as of Q3 2026.
Based on Procyon Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.